Skip to main content

Free Content India's Revised National Tuberculosis Control Programme: looking beyond detection and cure

SETTING: Pune District, Maharashtra State, India.

OBJECTIVES: To examine delays experienced by patients in accessing directly observed treatment.

DESIGN: Data were collected from 117 new sputum-positive patients using a semi-structured interview schedule.

RESULTS: Patient delays as well as diagnostic and treatment delays, which reflect the performance of a National TB Programme, were minimal. Provider delays, however, contributed significantly to delayed entry into India's Revised National TB Control Programme (RNTCP). Patients had to resort to multiple contacts with providers due to limitations of these providers in diagnosing or directing patients to the RNTCP. Patients who consulted a private provider participating in the public-private mix (PPM) were more likely to be suspected (OR 2.63, 90% CI 1.04–6.64) and referred (OR 6.8, 95%CI 2.08–22.21) to the RNTCP. Once the patients entered the RNTCP, the response of the system was rapid, with diagnosis offered and treatment initiated within on average 7 days.

CONCLUSION: Interventions aimed at providers to encourage early suspicion and referral to the RNTCP, such as the PPM, are more important in improving patient access to TB care than those focusing on reducing patient delays.

Keywords: India; PPM-DOTS; access; delays; tuberculosis

Document Type: Regular Paper

Affiliations: 1: Maharashtra Association of Anthropological Sciences, Centre for Health Research and Development, Pune, India 2: Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK 3: Departments of Infectious and Tropical Diseases and Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK 4: City TB Centre, Pimpri Chinchwad Municipal Corporation, Pune, India

Publication date: January 1, 2008

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content